Remove what-we-do
article thumbnail

Company Values: The Tools Behind What We Do

Imperical Blog

At Imperial Clinical Research Services, everything we do is rooted in our company values, which are integral to our success. … The post Company Values: The Tools Behind What We Do appeared first on Imperial Clinical Research Services Blog.

article thumbnail

Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)

Rethinking Clinical Trials

They held roundtable conversations with experts to understand their thoughts on what the FDA might do to better communicate, and they conducted polls and held 25 individual interviews. How do people want to hear that science is a moving target? Winckler, RPh, Esq) appeared first on Rethinking Clinical Trials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Six months after authorization, what do we know about Paxlovid?

pharmaphorum

As COVID-19 cases rise once again and the federal government gears up to increase distribution of Paxlovid, we thought we’d take this opportunity to review information about the drug and share new information that has come to light since it was first approved. What is Paxlovid and how was it developed? What are its side effects?

Drugs 105
article thumbnail

What do we know about lab automation? 

Drug Discovery World podcast

The latest episode of the free DDW podcast is titled “ What do we know about lab automation? ”. The articles are “What has 2020 taught us about lab automation?” It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas. .

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development? A recent draft from the FDA provides valuable insight.

article thumbnail

A doctor’s humbling journey treating long Covid: ‘The second we think we know what we are doing, we fall flat on our face’

STAT News

I first met Wes Ely in 2016, when I wrote about ICU delirium and Ely’s attempts, as a critical-care physician at Vanderbilt University Medical Center, to urge fellow health care workers to rethink the use of heavy sedation in ICUs.

article thumbnail

Why we remember, and forget. And what we can do about it

Medical Xpress

Neurologist Andrew Budson and neuroscientist Elizabeth Kensinger not only explain how memory works, but also share science-based tips on how to keep it sharp as we age in their new book, "Why We Forget and How to Remember Better: The Science Behind Memory." The book came out Wednesday.

75